Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Many people who received any of the authorized COVID-19 vaccines are now eligible for an additional dose of their choice.
Third booster dose may improve immune response in cancer patients without sufficient protection after second dose.
Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
The FDA is warning that these drugs used to treat advanced breast cancers may cause rare but severe inflammation of the lungs.
FDA approves immunotherapy plus targeted therapy combo for initial treatment of advanced renal cell carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.